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ABSTRACT
Background: The influence of gastric Helicobacter pylori 
infection on the development of oral pathoses remains unclear. 
The aim of this study is to examine the influence of gastric 
H. pylori infection on occurrence of halitosis and coated tongue. 
Materials and methods: Ninety-eight patients with dyspepsia 
were included in the study and their salivary samples and 
gastric biopsies were analyzed for the presence of H. pylori by 
Nested-PCR. Halitosis and coated tongue were assessed at 
the initial examination and 3 months after systemic eradication 
therapy against H. pylori. 
Results: Gastric biopsies of 66 patients were positive for 
H. pylori. Only one saliva sample was H. pylori positive. At initial 
examination, halitosis was observed in 20 patients (30.3%) out 
of 66 who had gastric H. pylori infection and in only 3 patients 
(9.4%) out of 32 without H. pylori infection (p = 0.0236). Coated 
tongue was diagnosed in 18 (27.2%) patients with the infection 
compared to only 2 (6.25%) patients negative for gastric 
H. pylori (p = 0.0164). Patients with gastric infection were treated 
with the triple eradication therapy (Amoxicillin, Clarythromycin, 
Pantoprazol) and their gastric biopsies and oral status were 
examined 3 months later. Halitosis was significantly more 
prevalent in the group of patients with persistent H. pylori 
infection (42.1%) compared to only 6.4% of patients in the 
group where infection was successfully eradicated (p = 0.0012). 
Coated tongue was diagnosed in 47.4% of patients where 
H. pylori was still present after eradication therapy and in only 
6.4% where eradication succeeded (p = 0.0003). 
Conclusion: Our findings suggest that eradication of gastric 
H. pylori significantly alleviates halitosis and coated tongue, 
the two oral conditions that may be considered as extragastric 
manifestations of this common chronic bacterial infection. 
Keywords: Coated tongue, Eradication therapy, Halitosis, 
H. pylori.
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INTRODUCTION
Helicobacter pylori is a microaerophylic, Gram-negative 
bacterium which primary ecological niche is the human 
stomach. H. pylori infection is one of the most common 
chronic bacterial infections worldwide, with more than 
half of the world’s population in both developed and 
developing countries being infected with this organism.4 
While infection is thought to be acquired in early child-
hood in most cases, epidemiological studies have also 
suggested new infections can be acquired during adult-
hood. Reported annual incidence rates vary significantly 
and range from 0 to 35%.8 The pathogenic properties of 
H. pylori include its ability to survive in the gastric juice, 
to escape the gastric acidity and to colonise the gastric 
mucosa. Infection with the organism is strongly associ-
ated with dyspeptic diseases (oesophagitis, peptic and 
duodenal ulcers, gastritis, duodenitis) and gastric cancer.5 
Current eradication regimen comprises of proton pump 
inhibitors and combination of antibiotics. Elimination of 
the infection greatly reduces the risk of disease relapse 
but in some cases the organism is not completely elimi-
nated at the first attempt and the recurrence of infection 
is well-documented.17 
In addition to the involvement in the local pathosis, 
H. pylori has been implicated in the pathogenesis of 
some extragastric diseases, such as idiopathic throm-
bocytopenic purpura, iron deficiency anemia, chronic 
idiopathic urticaria and hepatocellular carcinoma. There 
is also an increasing evidence for a possible association of 
H. pylori with cardiovascular diseases.15 Pathophysi-
ological mechanisms responsible for development of 
extragastic diseases include gastrointestinal blood loss 
and insufficient dietary iron absorption as well as auto-
immune mechanisms.9 
Halitosis and coated tongue are multifactorial oral 
conditions that can cause deep psychological stress to 
long time sufferers. A possible link between H. pylori 
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and breath odor was first suggested in 1993 and several 
later clinical studies reported close relationship between 
H. pylori infection, halitosis and glossitis.1 In addition, 
H. pylori has been shown to produce hydrogen sulphide 
and methyl mercaptan, implying that this microorganism 
could contribute to the development of halitosis.7
The tongue coating has been shown to be a major 
source of volatile sulfur compounds production.20 More 
than 700 bacterial species inhabit the oral cavity and 
the tongue coating, in particular, provides a reservoir 
for oral micro-organisms. Association between changes 
in tongue coating and gastric H. pylori infection has 
been indicated in various studies. Adler et al1 showed 
association between H. pylori infection, burning mouth 
syndrome, halitosis, and lingual papillary hyperplasia 
while Gall-Troselj et al6 reported connection between H. 
pylori, burning mouth syndrome and atrophic glossitis. 
The detection and isolation of the H. pylori from 
the gastric mucosa have been performed successfully, 
however, reports of extra-gastric isolation, primarily oral 
cavity, are still controversial.2 Additionally, the influence 
of local and gastric infections on development of oral 
pathology remains unclear.3
The aim of our study was to examine the association 
between gastric H. pylori infection, the presence of the 
bacterium in saliva, halitosis and coated tongue and the 
influence of systemic eradication therapy on these oral 
pathosis. 
MATERIALS AND METHODS
Subjects and Sampling
In this double-blind, case-control interventional clinical 
study, 98 subjects with dyspepsia (42 male and 56 female, 
age range from 19 to 78 years) were examined. All 
participants signed the consent form, before undergoing 
research procedures, agreeing to their participation 
in the clinical protocol. The study was approved by 
the Ethical Committee of the School of Dentistry, 
University of Belgrade. Exclusion criteria were the use 
of antimicrobials and Proton Pump Inhibitors within the 
3 months before the study, previous eradication therapy 
and hypersensitivity to amoxicillin or clarithromycin.
Two investigators assessed the presence of halitosis 
and the tongue coating index independently. All par-
ticipants received a letter with instructions. Two days 
before their appointment, they had to avoid garlic, onions, 
and spicy food in their diet. Twelve hours before the 
measurements, they also had to refrain from alcohol or 
coffee. On the morning of the appointment, they were 
forbidden to use chewing gums, mints, drops, scents, 
and mouth rinses. In contrast, they could perform normal 
oral hygiene (tooth brushing) and have breakfast. All 
measurements were recorded between 9:00 am and 12:00 
pm. The organoleptic halitosis score was determined at 
the distance of 10 cm by two trained judges who tested 
their ability to distinguish odors using the Smell Identi-
fication Test (Sensonics Inc, Haddon Heights, NJ, USA). 
Patients were instructed not to speak for several minutes 
prior to the examination. Organoleptic malodor scores14 
were recorded independently by each judge on a scale 
from 0 to 4 as follows: 0—no appreciable odor; 1 —slight 
oral malodor; 2—moderate oral malodor; 3—strong oral 
malodor and 4—very strong oral malodor. Patients were 
considered positive for halitosis if both examiners scored 
them 2 or higher.
Tongue coating index (TCI) was assessed by visual 
method based on observation of thickness of tongue 
coating as describe by Shimizu et al.16
Score 0: Tongue coating not visible.
Score 1: Tongue coating thin, papillae of tongue 
visible.
Score 2: Tongue coating very thick, papillae of tongue 
not visible.
Participants were regarded as to having coated tongue 
if both examiners gave score 1 or higher. In addition, 
unstimulated saliva was collected in a sterile tube during 
1 minute for H. pylori detection.
Subsequent to oral cavity inspection, all patients 
underwent upper esophagogastroduodenoscopy with 
biopsy, performed with GIF 165L endoscope, Olympus 
Co Tokyo, Japan. Two samples from the same patient were 
taken of the greater and lesser curvature of the gastric 
antrum up to 5 cm from the pylorus, and of lesion if any, 
and stored in a sterile tube containing 0.5 ml of Tris EDTA 
buffer, at –20ºC until PCR analyses. 
DNA Extraction and PCR Amplification
Whole DNA was extracted from saliva and gastric 
samples by the boiling method followed by Nested-PCR 
using species-specific primers for H. pylori. DNA from 
a reference strain ATCC 43629 H. pylori was used as a 
positive control. Following DNA extraction, 2 μl of DNA 
were used for PCR. The amplification was performed in 
a 25 μl mixture containing Taq DNA polymerase (1 unit/
reaction), PCR buffer (50 mM KCl, 10 mM Tris-HCl pH 
7.4 and 1.5 mM MgCl2), deoxynucleoside triphosphates 
(0.1mM/reaction of each dNTP) and primers (20 pmol 
each/reaction). All samples were amplified using a DNA 
thermal cycler (PCR Express, HYBAID Corp, USA). The 
cycling conditions were: initial denaturation at 94ºC for 3 
minutes and 35 cycles of: 94ºC (1 minute), 57ºC (1 minute), 
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72ºC (1 minute) and a final extension step at 72ºC for 5 
minutes. The first round of amplification was performed 
with the following primer pair (Applied Biosystems, UK) 
designated as outer primers:
5’-CAGTTATTTGGTGGCTACAACCG-3’and
5’-CCCATCAATAGACGCTTAATCC-3’
The expected PCR product size was 956 bp. After the 
first round of PCR, 2 μl of the final product were trans-
ferred to a fresh tube and reamplified using the same 
program and conditions as previously indicated, but with 
a primer pair designated as inner primers:
5’-GCTGTAATTTAAGGGTGGGGGTTG-3’ and
5’-TGCCGTAATTCAACTGCAAGCG-3’ with an 
expected PCR product of 345 bp.
Polyacrylamide Gel Electrophoresis
Ten microliter of final PCR products were mixed with 
2 μl of gel loading dye (0.25% bromophenol blue, 30% 
glycerol and 10 mM Tris EDTA, pH 7.6), loaded into 8% 
polyacrylamide gel and electrophoresed using 1 × TEA 
buffer. DNA fragments were visualized after staining 
with ethidium bromide using a BIO-RAD GEL-DOC 1000 
detection system.
Study Design
Following the assessment of gastric H. pylori infection 
by Nested-PCR, 66 subjects positive for gastric infection 
were given the triple eradication therapy which consisted 
of Amoxicillin 2 g/day (g/d), Clarithromycin 1 g/d and 
Pantoprazole 80 mg/d, for 7 days. Three months after the 
completion of the eradication therapy all 66 participants 
underwent control examination with oral and endoscopic 
evaluation, taking samples as at the beginning of the 
study. 
Statistical Analysis
The occurrence of halitosis and coated tongue was 
compared between the patients with gastric H. pylori 
infection and those without detected bacterium in their 
biopsy samples, both before and after the eradication 
therapy. Comparisons were performed using a two-tails 
Fisher’s test. The significance was set at p-value of < 0.05. 
RESULTS
At initial examination H. pylori was detected in gastric 
samples of 66 out of 98 examined subjects with dyspepsia, 
using Nested-PCR method. Only one saliva sample was 
positive for H. pylori. Halitosis was observed in 20 patients 
(30.3%) who had gastric infection and in only 3 patients 
(9.4%) out of 32 without H. pylori infection (p = 0.0236). 
Coated tongue was diagnosed in 18 (27.2%) patients with 
the infection compared to only 2 (6.25%) patients negative 
for gastric H. pylori (p = 0.0164) (Table 1).
Three months after the completion of the eradication 
therapy 47 (71%) patients out of originally 66 infected 
were negative for gastric H. pylori while 19 (29%) of them 
still harbored the bacterium in their stomach. All of the 
saliva samples were now negative for H. pylori. Halitosis 
was observed in 8 (42.1%) subjects with persistent gastric 
infection and in only 3 subjects (6.4%) from the group 
where infection was successfully eradicated (p = 0.0012). 
Coated tongue was diagnosed in 9 patients (47.4%) where 
H. pylori was still present in gastric biopsies and in only 
3 patients (6.4%) where eradication therapy succeeded 
(p = 0.0003) (Table 2).
DISCUSSION
There is a strong correlation between H. pylori infection 
with gastritis, gastric and duodenal ulcer and the 
development of gastric cancer.11 However, the association 
between gastric H. pylori infection and oral pathology is 
still controversial. Some studies have indicated possible 
involvement of H. pylori in the pathogenesis of glossitis, 
halitosis, burning mouth syndrome, recurrent aphthous 
ulcerations and even periodontitis.13 Detection of H. 
pylori in oral samples varies significantly, ranging from 
0 to 100%.19 Studies evaluating prevalence of H. pylori in 
the oral cavity showed conflicting data and influence of 
the local infection on oral pathology is not clear.12 The 
number of H. pylori detected in oral samples is usually 
very small and its presence may be only transient 
resulting from gastric reflux, a symptom common in 
gastroesophageal diseases.2 Moreover, even if it is present 
in the mouth, systemic eradication therapy has been 
shown to have 100% eradication rate for oral H. pylori 
Table 1: Significantly higher prevalence of halitosis and coated 
tongue in patients with gastric Helicobacter pylori infection at 
initial examination
Gastric samples Halitosis Coated tongue Total patients
H. pylori + 20 (30.3%) 18 (27.2%) 66
H. pylori – 3 (9.4%) 2 (6.25%) 32
P (Fisherman’s) 0.0236 0.0164
H: Helicobacter
Table 2: Significant correlation of halitosis and coated tongue 
with the persistent gastric Helicobacter pylori infection (follow-up 
examination)
Gastric samples Halitosis Coated tongue Total patients
H. pylori + 8 (41.2%) 9 (47.4%) 19
H. pylori  – 3 (6.4%) 2 (6.4%) 47
P (Fisherman’s) 0.0012 0.0003
H: Helicobacter
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as opposed to 78% for stomach infection.2 In our study, 
H. pylori was detected in only one of the saliva samples 
taken during initial examination and in none of the 
samples taken after the eradication therapy. This finding 
rules out the influence of local H. pylori infection on 
development of halitosis and coated tongue. In addition, 
Kinberg et al10 has reported that gastrointestinal 
pathology was very common in patients with halitosis 
regardless of their dental and otolaryngological findings. 
It has also been shown that local therapy with antiseptic 
mouthwashes is ineffective as a treatment of halitosis in 
subjects with gastric H. pylori infection.17
Our results indicate association between gastric H. 
pylori infection, halitosis and coated tongue and show 
for the first time that these two oral conditions are 
significantly improved after successful gastric eradication 
of this bacterium. At initial examination, about one third 
of infected patients suffered from halitosis and coated 
tongue, compared to only less than 10% of patients with 
dyspeptic diseases but without gastric H. pylori infection. 
Three months after completion of applied triple therapy, 
H. pylori was eradicated in 71.2% of patients. Half of the 
patients where eradication therapy failed and who had a 
recurrence of infection, still suffered from coated tongue 
and halitosis, while in the group where H. pylori was 
successfully eradicated the prevalence of halitosis and 
coated tongue was significantly lower (6%).
Several other studies have found a higher rate of 
halitosis among H. pylori positive patients with dyspeptic 
diseases than in those who were H. pylori negative.18 
Hoshi et al reported that levels of hydrogen-sulfide and 
dimethyl-sulfide in mouth air were significantly higher 
in H. pylori positive then in H. pylori negative patients.7 
In addition, gastric H. pylori infection has also been 
associated with lingual hyperplasia, burning mouth 
syndrome and atrophic glossitis.22 In this interventional 
study, we showed for the first time that successful 
eradication of gastric H. pylori ameliorated halitosis and 
coated tongue. 
CONCLUSION
Our findings implicate clear association between gastric 
H. pylori infection and occurrence of halitosis and 
coated tongue. Eradication of gastric H. pylori infection 
significantly improves these two very common oral 
conditions.
CLINICAL SIGNIFICANCE
In the absence of local factors, patients with persistent 
halitosis and coated tongue should be referred to and 
treated by gastroenterologists.
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